MiR-124-3p Suppresses Prostatic Carcinoma by Targeting PTGS2 Through the AKT/NF-κB Pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Link
https://link.springer.com/content/pdf/10.1007/s12033-021-00326-7.pdf
Reference26 articles.
1. Yedjou, C. G., Mbemi, A. T., & Noubissi, F. (2019). Prostate cancer disparity, chemoprevention, and treatment by specific medicinal plants. Nutrients, 11, 336
2. Odero-Marah, V., Hawsawi, O., Henderson, V., & Sweeney, J. (2018). Epithelial-Mesenchymal Transition (EMT) and prostate cancer. Advances in Experimental Medicine and Biology, 1095, 101–110
3. Mishra, S., Yadav, T., & Rani, V. (2016). Exploring miRNA based approaches in cancer diagnostics and therapeutics. Critical Reviews in Oncology/Hematology, 98, 12–23
4. Long, H. D., Ma, Y. S., Yang, H. Q., Xue, S. B., Liu, J. B., Yu, F., Lv, Z. W., Li, J. Y., Xie, R. T., Chang, Z. Y., Lu, G. X., Xie, W. T., Fu, D., & Pang, L. J. (2018). Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma. Molecular Biology Reports, 45, 2615–2623
5. Zo, R. B., & Long, Z. (2018). MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B. Journal of Cellular Physiology, 234, 464–474
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Study on quality control methods and pharmacodynamic material basis of different specifications of Corydalis Rhizoma produced in Zhejiang Province;Journal of Ethnopharmacology;2024-10
2. Prostate Cancer Prediction Model Based on Anoikis-Related Genes and Therapeutic Potential of BUB1 in Influencing Epithelial-Mesenchymal Transition;2024-08-26
3. Discussion on the Influence of Gpx 4 Target in the Field of Cancer;Current Medicinal Chemistry;2024-02-20
4. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer;Clinical and Translational Oncology;2023-12-09
5. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer;2023-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3